Cooper Companies | COO - Assets


Cooper Companies reported $12.67B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Abbott USD 108.25B 968M Sep/2026
Align Technology USD 6.52B 103.03M Sep/2026
AtriCure USD 717.54M 40.89M Sep/2026
Bausch Health Companies USD 25.48B 690M Sep/2026
Baxter International USD 19.41B 377M Sep/2026
Bayer EUR 113.47B 6.18B Sep/2026
Becton, Dickinson and Co. USD 50.79B 60M Sep/2026
Boston Scientific USD 45.46B 245M Sep/2026
Cooper Companies USD 12.67B 191.1M Jun/2026
Dentsply International USD 5.19B 14M Sep/2026
Dexcom USD 6.24B 216.5M Sep/2026
Edwards Lifesciences USD 14.14B 277.3M Sep/2026
Globus Medical USD 5.53B 39.93M Sep/2026
Haemonetics USD 2.41B 45.2M Sep/2026
Inogen USD 307.01M 5.03M Sep/2025
Insulet USD 3.42B 250M Sep/2026
Integra LifeSciences USD 3.51B 55.69M Sep/2026
Intuitive Surgical USD 19.35B 1.53B Sep/2026
J&J USD 197.42B 3.64B Sep/2026
Medtronic USD 93.31B 278M Jun/2026
Merit Medical Systems USD 2.92B 61.29M Sep/2026
Novartis USD 117.15B 1.38B Sep/2026
ResMed USD 8.21B 754.14M Sep/2026
STAAR Surgical USD 485.16M 9.95M Sep/2026
Steris USD 10.71B 22.5M Sep/2026
Stryker USD 47.25B 683M Sep/2026
Tandem Diabetes Care USD 1.16B 5.29M Sep/2026
Teleflex USD 6.35B 438.92M Sep/2026
Utah Medical Products USD 124.38M 1.84M Mar/2026
Zimmer Biomet Holdings USD 23.54B 740.8M Sep/2026